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Introduction
Falls affect a large proportion of persons aged ≥65 years [1] , and are associated with high morbidity and mortality rates [2, 3] . Fall-related injuries place a substantial burden on healthcare systems due to large numbers of visits to Emergency Departments (ED), hospital admissions and admissions to long-term care facilities [4] [5] [6] [7] [8] [9] .
The use of fall-risk-increasing-drugs (FRIDs), including psychotropic and cardiovascular drugs, is associated with an increased risk of falls and related injuries [10] [11] [12] [13] . Although FRIDs withdrawal is frequently incorporated in multifactorial intervention programmes, evidence regarding overall FRIDs withdrawal as a single intervention is scarce [14] .
We investigated the effect of FRIDs withdrawal versus 'care as usual' on reducing falls in community-dwelling older men and women [15] .
Methods
The IMPROveFALL study is a randomised, multicentre trial, assessing the effect of FRIDs withdrawal versus 'care as usual' as a method for falls reduction [15] . The study protocol, including the list of FRIDs, has been published previously [15] . Patients meeting the following inclusion criteria were eligible for enrolment: aged ≥65 years, community-dwelling, ED-visit because of a fall [16] and use of one or more FRIDs [10, 11, 13, 15] . The follow-up period was 12 months. The study was performed in accordance with the Declaration of Helsinki; all participants gave written informed consent. The Medical Research Ethics Committees in all participating hospitals approved the study protocol.
Intervention
During the visit to the research outpatient clinic, a fallrelated assessment was performed by the research physician. Medical history and medication use, including drug type, daily dose and duration of use were registered. Collected data were verified with records from the patient's General Practitioner (GP) and local pharmacist. Randomisation was done by the research physician using the trial website. In the 'care as usual' group, the medication was not changed. In the intervention group, FRIDs, as defined in the literature [10, 11, 13, 17] , and in the ensuing study protocol [15] , were discontinued or reduced where safely possible.
Monitoring of falls
All participants received a Falls Calendar for reporting falls during a 1-year follow-up. Falls were recorded weekly on the Falls Calendars, which were returned every 3 months. The first GP-consultation and first ED-visit because of a fall were collected from above-mentioned Falls Calendars and GP records.
Statistical analyses
Analyses were performed using the Statistical Package of the Social Sciences version 17.0, Chicago, IL.
After sample size calculations, our aim was to include a total number of 620 participants in the study, 310 in the control group and 310 in the intervention group [15] . Data were analysed according to the intention-to-treat principle (primary) and per-protocol (secondary). The hazard ratios for falling were calculated using a Cox-regression model. Herein, the time between the start of follow-up and the first fall served as primary outcome measure. The time between the start of follow-up and the second fall, first GPconsultation and first ED-visit because of a fall were also analysed. Differences in cumulative incidence of falls, GPconsultations and ED-visits were analysed using Poisson regression, adjusted for overdispersion because of interdependence among the dependent variable (falls). Subgroup analyses were performed, assessing the separate effect of cardiovascular and psychotropic drug withdrawal.
Predefined models were constructed in order to adjust for age, gender and other potential confounders. Confounders that led to a change in the regression coefficient (B) of ≥10% were retained in the multivariate-adjusted regression model. A P-value of <0.05 was used as threshold for statistical significance.
Results
A total of 612 participants were randomised in the IMPROveFALL study. Randomisation resulted in 293 participants being allocated to the control group and 319 participants to the intervention group (see Supplementary data, Appendix 1, available in Age and Ageing online). For the intention-to-treat analyses, 21 participants in the control group and 11 participants in the intervention group were excluded due to withdrawal from study or death. For the per-protocol analyses, 9 participants in the control group and 66 participants in the intervention group were excluded due to protocol violations.
The mean age of the participants was 76 years, 62% were female. There were no differences in baseline characteristics between the intervention and control group (see Supplementary data, Appendix 2, available in Age and Ageing online). The mean number of drugs and FRIDs used at baseline were six and four, respectively. Figure 1 specifies number of participants compliant to attempted interventions according to FRID categories; Table 1 includes the specific drug types. Participants using multiple types of FRIDs, e.g. psychotropic and cardiovascular FRIDs, are presented in both categories. Notably, in 40% of all FRIDs, an intervention was not deemed possible or necessary. Of all attempted FRID withdrawals, 35% was unsuccessful, either due to recurrence of the initial indication for prescribing, additional medication for newly diagnosed conditions or non-compliance.
The percentage of participants using ≥3 FRIDs at baseline was 72% in the control group and 70% in the intervention group; these percentages did not decrease after 1-year follow-up, 75% and 70%, respectively (see Supplementary data, Appendix 3, available in Age and Ageing online). Furthermore, 22% and 25% of the control and intervention group used a higher number of FRIDs after 12 months follow-up than at baseline (see Supplementary data, Appendix 4, available in Age and Ageing online).
The number of participants in the control group (n = 91; 34%) and intervention group (n = 115; 37%) experiencing a fall during the 1-year follow-up did not differ significantly (P = 0.33). Similarly, the number of participants in the control group (n = 38; 14%) and intervention group (n = 50; 16%) experiencing a recurrent fall during the 1-year follow-up did not differ significantly (P = 0.45). Also, the number of fallers requiring a GP-consultation (n = 46; 17% versus 36; 12%, P = 0.07) or ED-visit (n = 21; 8% versus 16; 5%, P = 0.22) did not differ significantly between the two groups.
Cox-regression analyses adjusted for age and gender showed that FRIDs-withdrawal had no significant effect on the time to first fall, or on the time to the second fall (see Supplementary data, Appendix 5, available in Age and Ageing online). Similarly, no significant effect on the time to the first GPconsultation or the time to the first ED-visit because of a fall was found. Subgroup analyses of cardiovascular and psychotropic FRIDs-withdrawal were similar, except for a significantly increased time until the first GP-consultation because of a fall after cardiovascular FRIDs-withdrawal. The perprotocol analyses did not alter the results.
Poisson regression analyses showed FRIDs-withdrawal did not have a significant effect on the cumulative incidence of falls. Subgroup analyses of cardiovascular and psychotropic FRIDs-withdrawal were again similar, and per-protocol analyses did not alter these results (see Supplementary data, Appendix 6, available in Age and Ageing online).
Discussion
In the current RCT, the single intervention of FRIDswithdrawal was not effective in reducing falls.
There are several possible reasons for our main findings. First, a possible positive interpretation is that prescribing of these drugs, which will have involved a weighing up of benefit and risk, both before the fall and in the represcribing over the subsequent year, was already fairly satisfactory. However, the number of FRIDs the participants were taking and the increase in FRIDs over time remains concerning. Second, in the intervention group, there was limited compliance, especially concerning psychotropic drugs withdrawal. Finally, when examining the participants in the successful withdrawal group individually, it was apparent that even when one or more FRIDs were successfully withdrawn or reduced, several participants were prescribed additional FRIDs, often for new conditions, during the follow-up year, either by their GP or another specialty. This indicates that FRIDs-withdrawal is difficult to maintain over 1 year, in a population of complex, multimorbid older fallers. FRIDs-withdrawal has previously been shown to be safely possible and effective [17] [18] [19] . In the study by Pit et al., the intervention was carried out by the participants' GP, resulting in a greater number of successful withdrawals, probably due to a substantial doctor-patient relationship [19] . Campbell et al. demonstrated the effectiveness of total psychotropic drugs withdrawal on preventing falls in the short term [18] . However, as in our study, compliance was difficult to maintain. Two intervention studies showed no significant reduction in falls or in overall use of high-risk medications, both these studies implemented the intervention within a less substantial doctor-patient relationship [20, 21] .
The following limitations should be taken into account. First, recruiting participants proved challenging, the recruitment-period lasted 4 years despite enroling six hospitals. Reasons for refusing to participate have been reported previously, i.e. mobility impairment and lack of transport [22] . Second, as mentioned before, in the intervention group compliance with FRIDs-withdrawal was limited. This may have affected our outcome, but also mirrors clinical practice. In conclusion, in this population of complex multimorbid older men and women visiting an ED because of a fall, the single intervention of FRIDs-withdrawal was not effective in reducing falls.
In the subgroup analysis, there was a significantly increased time to first GP-consultation because of a fall after withdrawal of a cardiovascular FRID. If this was due to the type of fall, the intervention, whilst not clinically useful overall, might be useful if targeted at certain types of falls. The current study cannot answer this question. We recommend that future studies about the effects of FRIDs-withdrawal on falls prevention also investigate the type of fall (e.g. presyncope or syncope); this might provide helpful information on which FRID should be withdrawn in which patient [23] .
Key points
• The single intervention of FRIDs-withdrawal was not effective in reducing falls.
• FRIDs-withdrawal is difficult to maintain.
• The prescribing of FRIDs is already fairly satisfactory.
• However, the increase in FRIDs over time remains concerning. 
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